Form EFFECT Semnur Pharmaceuticals,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 29, 2025 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LAWSUIT ALERT: Investors in FS KKR Capital Corp. (NYSE: FSK) shares should contact the Shareholders Foundation
- UL Research Institutes’ Alejandro Lozano Shares How to Take C.H.A.R.G.E. of Battery Safety with YourUpdateTV
- Edge Total Intelligence Announces Entrance Into Investor Rights Agreement, Amendment to Circular, and Extension of Proxy Deadline
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share